Susan Carroll Chrysostomou

Susan is a senior associate in the firm’s Corporate M&A Group with a particular focus on equity capital markets.  In her transactional practice, Susan specialises in public M&A (both hostile and recommended) and corporate reorganisations and restructurings. 

In addition to her transactional practice, Susan counsels corporate clients on complex company law, governance, compliance and securities law issues. This advice is often provided to boards and individual directors in situations where the satisfaction of their fiduciary duties may be subject to public scrutiny.

Prior to joining the Corporate M&A Group, Susan worked in Matheson’s Corporate Restructuring and Insolvency Department.

Susan is co-author of the Irish chapter of Getting the Deal Through: Mergers & Acquisitions 2018 and has contributed to numerous other publications, including the Irish chapter of the International Comparative Legal Guide to Mergers & Acquisitions 2018.

Susan has advised:

• Aon, a leading global professional services firm, on its corporate redomiciliation from the UK to Ireland and the listing of the new Irish holding company, Aon plc, on the NYSE;
• Weatherford International plc, the Irish registered, NYSE listed parent of the Weatherford group of companies, on one of the largest and most complex cross-border corporate restructurings of 2019, and the largest in Irish corporate history. In a highly innovative legal structure, the transaction, which involved a $7.4 billion debt-for-equity swap and refinancing, was implemented through the first ever combined use of the US Chapter 11 bankruptcy process and an Irish examinership restructuring process;
• Cimpress on its corporate redomiciliation from the Netherlands to Ireland and the listing of the new Irish holding company, Cimpres plc, on Nasdaq;
• Gurnet Point L.P. (a $2 billion healthcare investment fund) on its $209 million public takeover of Innocoll Pharmaceuticals plc (a Nasdaq-listed, global pharmaceutical and medical device company), by way of scheme of arrangement under the Irish Companies Act and pursuant to the Irish Takeover Panel Rules;
• Nexvet Biopharma plc (a Nasdaq-listed bio-pharmaceutical company) on its $85 million public takeover by Zoetis (the global leading animal health company with revenues of $4.9 billion), by way of scheme of arrangement under the Irish Companies Act and pursuant to the Irish Takeover Panel Rules; and
• Worldview Capital (a private investment management firm) on its hostile takeover of Petroceltic International plc (then listed on AIM and ESM and engaged in oil and gas exploration) and its subsequent global reorganisation of the Petroceltic group.

• Admitted as a solicitor in Ireland - 2015
• University College Dublin, Master of Laws (Commercial) - 2010
• University College Dublin, Bachelor of Civil Law - 2009